The stent debate continues.
NEJM — Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction
Background Sirolimus-eluting stents reduce rates of restenosis and reintervention, as compared with uncoated stents. Data are limited regarding the safety and efficacy of such stents in primary percutaneous coronary intervention (PCI) for acute myocardial infarction with ST-segment elevation.
Related posts:
- FDA Statement on Coronary Drug-Eluting Stents
- Abbott Begins Early International Launch of XIENCE™ Everolimus Eluting Coronary Stent System
- Clinical and Angiographic Outcomes After Placement of Multiple Overlapping Drug-Eluting Stents in Diffuse Coronary Lesions
- J&J – Conor CoStar(r) Clinical Trial Stent Stopped
- Do drug eluting stents DES increase deaths?



Trackbacks/Pingbacks
[...] contact _uacct = “UA-312296-3″; urchinTracker(); « NEJM — Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction 16.09.06 [...]
[...] More here. By admin Feedbacks on this entry via RSS 2.0 Please leave a Comment or discuss via Trackback! Comments Please Leave aComment! [...]
[...] post here By admin Feedbacks on this entry via RSS 2.0 Please leave a Comment or discuss via Trackback! Comments Please Leave aComment! [...]
[...] significant superiority to the TAXUS® paclitaxel-eluting coronary stent system”. Related post here [?] Share [...]